Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 19 items.
Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.…
RecallHealth product recall | 2022-08-08
Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.
Atorvastatin is a…
AlertPublic advisory | 2022-08-06
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA).
RecallHealth product recall | 2022-07-28
UPDATE (July 28, 2022): Update: Apotex recalls additional Apo-Acyclovir tablets due to a nitrosamine impurity
Apotex Inc. is recalling four additional lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a…
AlertPublic advisory | 2022-07-28
The sterility is out of specification in the affected lot (Periodic Media Fill Validation failure).
RecallHealth product recall | 2022-06-30
Rocky Mountain Soap Company recalls all lots of two Broadspectrum solar protection products due to quality concerns linked to deficiencies in Good Manufacturing Practices (GMP). The microbial content/ total aerobic microbial content may be out of…
RecallHealth product recall | 2022-06-16
The affected lot is recalled due to a microbiological contamination.
RecallHealth product recall | 2022-04-27
UPDATE: April 21, 2022 – Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
Pfizer Canada ULC is recalling all lots of the prescription drug Accupril (quinapril hydrochloride) in 10 mg, 20 mg and 40 mg strengths due to the…
AlertPublic advisory | 2022-04-21
Presence of N-Nitroso-quinapril above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2022-04-20
Presence of impurity N-Nitroso-quinapril above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2022-03-04
Presence of impurity N-Nitroso-propanolol above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2022-03-02
Pfizer Canada ULC is recalling all lots of Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths, due to the presence of a nitrosamine impurity (N-nitroso-propranolol) above the acceptable level…
AlertPublic advisory | 2022-03-01
UPDATE: January 26, 2022
Certain lots of Elavil (amitriptyline) and APO-Amitriptyline recalled due to a nitrosamine impurity
AA Pharma Inc. is recalling two lots of Elavil (amitriptyline) (lots PY1829 and PY1830) and Apotex Inc. is recalling one…
AlertPublic advisory | 2022-01-26
Presence of N-nitrosodimethylamine (NDMA) above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2021-12-03
Affected lots may contain the presence of benzene contamination.
RecallHealth product recall | 2021-11-19